Bicara Therapeutics Inc. Company Profile
NASDAQ: BCAXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 8, 10:59 AM ET
Bicara Therapeutics at a glance
Bicara Therapeutics Inc. (NASDAQ: BCAX) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Boston, MA. Bicara Therapeutics is led by Dr. Claire Mazumdar Clemon M.B.A., Ph.D. and employs about 103 people. The company's shares have traded publicly since 2024.
At a market capitalization of $1.10 billion, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0002023658, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Bicara Therapeutics do?
Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody bound to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.
Business description based on the company's public filings.
Company information
- Legal name
- Bicara Therapeutics Inc.
- Ticker
- NASDAQ: BCAX
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Dr. Claire Mazumdar Clemon M.B.A., Ph.D.
- Employees
- 103
- Headquarters
- 116 Huntington Avenue, Boston, MA, United States
- Phone
- 617 468 4219
- Website
- bicara.com
- IPO year
- 2024
- Market cap
- $1.10B
- SEC CIK
- 0002023658
Companies similar to Bicara Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| AMPHAmphastar Pharmaceuticals Inc. | 25.75 | +0.80% | $1.10B | vs BCAX |
| TRAXFirst Tracks Biotherapeutics Inc. | 30.62 | +0.10% | $1.09B | vs BCAX |
| MNKDMannKind Corporation | 3.45 | -0.14% | $1.11B | vs BCAX |
| LBRXLB Pharmaceuticals Inc | 33.60 | -1.64% | $1.08B | vs BCAX |
| AVLNAvalyn Pharma Inc. | 25.02 | -2.00% | $1.11B | vs BCAX |
| JANXJanux Therapeutics Inc. | 17.50 | -2.34% | $1.07B | vs BCAX |
| ORICOric Pharmaceuticals Inc. | 11.02 | -8.24% | $1.14B | vs BCAX |
| HROWHarrow Inc. | 30.54 | -0.28% | $1.14B | vs BCAX |